These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 8882303)

  • 1. Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships.
    Sica DA; Gehr TW
    Clin Pharmacokinet; 1996 Mar; 30(3):229-49. PubMed ID: 8882303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to loop diuretics. Why it happens and what to do about it.
    Brater DC
    Drugs; 1985 Nov; 30(5):427-43. PubMed ID: 3905337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination diuretic therapy in severe congestive heart failure.
    Dormans TP; Gerlag PG; Russel FG; Smits P
    Drugs; 1998 Feb; 55(2):165-72. PubMed ID: 9506239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systematic Review and Meta-Analysis of Metolazone Compared to Chlorothiazide for Treatment of Acute Decompensated Heart Failure.
    Steuber TD; Janzen KM; Howard ML
    Pharmacotherapy; 2020 Sep; 40(9):924-935. PubMed ID: 32639593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and management of diuretic resistance in congestive heart failure.
    De Bruyne LK
    Postgrad Med J; 2003 May; 79(931):268-71. PubMed ID: 12782772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.
    Shulenberger CE; Jiang A; Devabhakthuni S; Ivaturi V; Liu T; Reed BN
    Pharmacotherapy; 2016 Aug; 36(8):852-60. PubMed ID: 27393709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of diuretics in congestive heart failure.
    Brater DC
    Semin Nephrol; 1994 Sep; 14(5):479-84. PubMed ID: 7997652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional state of the nephron and diuretic dose-response--rationale for low-dose combination therapy.
    Knauf H; Mutschler E
    Cardiology; 1994; 84 Suppl 2():18-26. PubMed ID: 7954541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of diuretics in cirrhosis and nephrotic syndrome.
    Brater DC
    Semin Nephrol; 1999 Nov; 19(6):575-80. PubMed ID: 10598545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature.
    Rosenberg J; Gustafsson F; Galatius S; Hildebrandt PR
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):301-6. PubMed ID: 16189620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diuretic therapy in acute heart failure].
    Trullàs JC; Morales-Rull JL; Formiga F
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of Diuretic Resistance and Its Implications for the Management of Chronic Heart Failure.
    Wilcox CS; Testani JM; Pitt B
    Hypertension; 2020 Oct; 76(4):1045-1054. PubMed ID: 32829662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Intravenous Chlorothiazide for Refractory Acute Decompensated Heart Failure Unresponsive to Adjunct Metolazone.
    Cardinale M; Altshuler J; Testani JM
    Pharmacotherapy; 2016 Aug; 36(8):843-51. PubMed ID: 27321568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diuretics in therapy of "diuretic resistance" by patients with congestive heart failure].
    Tůma P; Hrdý P
    Vnitr Lek; 2006 Sep; 52(9):782-9. PubMed ID: 17091601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diuretic-based therapy].
    Presne C; Monge M; Mansour J; Oprisiu R; Choukroun G; Achard JM; Fournier A
    Nephrol Ther; 2007 Oct; 3(6):392-426. PubMed ID: 17919642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diuretic treatment and diuretic resistance in heart failure.
    Krämer BK; Schweda F; Riegger GA
    Am J Med; 1999 Jan; 106(1):90-6. PubMed ID: 10320123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of loop diuretics with thiazide-type diuretics in heart failure.
    Jentzer JC; DeWald TA; Hernandez AF
    J Am Coll Cardiol; 2010 Nov; 56(19):1527-34. PubMed ID: 21029871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretic resistance: mechanisms and therapeutic strategies.
    Brater DC
    Cardiology; 1994; 84 Suppl 2():57-67. PubMed ID: 7954547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.